tiprankstipranks

Mitchell Shuster Steiner Insider Profile

4 Followers
Mitchell Shuster Steiner, CEO, Director at Oncternal Therapeutics, holds 7.09M shares in Veru (Ticker: VERU), holds 6.54M shares in Oncternal Therapeutics (Ticker: ONCT). Most recently, Mitchell Shuster Steiner Sold ― shares of Veru on May 24, 2024 for an estimated value of 87.34K.
tipranks
Mitchell Shuster Steiner

Mitchell Shuster Steiner
Oncternal Therapeutics (ONCT)
CEO, Director

Ranked #11,321 out of 97,997 Corporate Insiders

Profitable Transactions

53%
8 out of 15 Profitable Transactions

Average Return

+11.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$53M
87.46%
12.54%
A breakdown of Mitchell Shuster Steiner's holdings

Insider Roles

Oncternal Therapeutics
(ONCT)
CEO, Director
Veru
(VERU)
President & CEO, Director
Roles that Mitchell Shuster Steiner holds in companies

Most Profitable Insider Trade

Stock:
Veru
(VERU)
Rating:Informative Buy
Date:Jun 12, 2017 - Jun 12, 2018
Return:+81.40%
The most profitable trade made by Mitchell Shuster Steiner

Mitchell Shuster Steiner's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Oncternal Therapeutics
Jul 16, 2012
CEO, Director
Informative Sell
464.70K
$46.31M
Veru
May 24, 2024
President & CEO, Director
Informative Sell
87.34K
$6.64M
List of latest transactions for each holding click on a transaction to see Mitchell Shuster Steiner's performance on stock

Mitchell Shuster Steiner insider profile FAQ

What is the percentage of profitable transactions made by Mitchell Shuster Steiner?
The percentage of profitable transactions made by Mitchell Shuster Steiner is 53%.
    What is the average return per transaction made by Mitchell Shuster Steiner?
    The average return per transaction made by Mitchell Shuster Steiner is 11.00%.
      What stocks does Mitchell Shuster Steiner hold?
      Mitchell Shuster Steiner holds: ONCT, VERU stocks.
        What was Mitchell Shuster Steiner’s latest transaction?
        Mitchell Shuster Steiner latest transaction was an Informative Sell of $87.34K.
          What was Mitchell Shuster Steiner's most profitable transaction?
          Mitchell Shuster Steiner’s most profitable transaction was an Informative Buy of VERU stock on June 12, 2017. The return on the trade was 81.40%.
            What is Mitchell Shuster Steiner's role in Oncternal Therapeutics?
            Mitchell Shuster Steiner's role in Oncternal Therapeutics is CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.